Crossbow Therapeutics vs ImmunityBio
Crossbow Therapeutics vs ImmunityBio, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Crossbow Therapeutics is on 55/100 and ImmunityBio on 44/100.
Where each one leads
Crossbow Therapeutics
- our overall score: 55/100 against 44/100
- agent readiness: 45/100 against 26/100
- funding raised: $157M against $75.0M
ImmunityBio
- domain rating: 53/100 against 25/100
- headcount: 620 against 40
At a glance
| Measure | Crossbow Therapeutics | ImmunityBio |
|---|---|---|
| What it is | Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes. | A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases. |
| Category | Biotechnology, Pharmaceuticals, Cancer, Immunotherapy | Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2021 | 2014 |
| Headquarters | Cambridge, United States | Culver City, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Crossbow Therapeutics | ImmunityBio |
|---|---|---|
| Employees | 40 | 620 |
| Total funding | $157M | $75.0M |
| Latest round | Series B | Funding Round |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 32,397 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Crossbow Therapeutics | ImmunityBio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 44/100 |
| Traction | 56/100 | 59/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 15/100 | 33/100 |
| Quality | 65/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (45/100) | F (26/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 53/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Crossbow Therapeutics | ImmunityBio |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Wix | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager, Facebook Pixel |
| Support stack | Not detected | HubSpot |
| Open source | Yes | No |
Crossbow Therapeutics vs ImmunityBio: common questions
Which is better, Crossbow Therapeutics or ImmunityBio?
On our 0-100 score Crossbow Therapeutics rates higher (55/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Crossbow Therapeutics and ImmunityBio compare on the numbers?
Crossbow Therapeutics leads on our overall score (55/100 against 44/100), agent readiness (45/100 against 26/100), funding raised ($157M against $75.0M). ImmunityBio leads on domain rating (53/100 against 25/100), headcount (620 against 40).
Read the full Crossbow Therapeutics review and pricing or the ImmunityBio review and pricing. You can also browse other Crossbow Therapeutics alternatives we track.